[Clinical experience with cefbuperazone in complicated urinary tract infection].
Cefbuperazone (CBPZ) was administered to inpatients with complicated urinary tract infections (UTI) at our department. Clinical efficacy and safety were evaluated in 22 chronic cases by the criteria for evaluation of clinical of antimicrobial agents on urinary tract infection. Overall clinical efficacy was excellent in 8 cases, moderate in 9 cases and poor in 5 cases with an effectiveness rate of 77%. Twenty-four of the 34 strains isolated from the patients were eradicated and eradication rate was 71%. Neither subjective nor objective adverse reactions were observed. Abnormal changes in laboratory tests were found in 9 patients, but were probably not related to CBPZ administration. Judging from these results, CBPZ is considered to be an effective and safe antibacterial for the treatment of complicated UTI.
Banya
Y
Y
Department of Urology, School of Medicine, Iwate Medical University.
Okamoto
T
T
Ujiie
T
T
Yoo
T
T
Noro
K
K
Niisato
S
S
Yokota
K
K
Aoki
H
H
Kubo
T
T
Ohhori
T
T
D000328:Adult; D000368:Aged; D002513:Cephamycins / Q000627:therapeutic use*; D003556:Cystitis / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011704:Pyelonephritis / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000150:complications / Q000188:drug therapy*
D002513:Cephamycins; C035978:cefbuperazone